Blog Standard

Unraveling the Complexities of Product-By-Process Patent Claims: Insights from the Vifor vs. Dr. Reddy’s Case

Introduction A recent judgment by the Delhi High Court in Vifor International Ltd & Anr. vs Defendants has shed light on the intricate realm of product-by-process patent claims and their implications for patentability and infringement. Presently, as per practice guidelines followed by Indian Patent Office (‘IPO’) in prosecuting patent applications pertaining to ‘product-by-process’ claim, the […]
Read more

Impact of the Draft Patents (Amendment) Rules, 2023 on the Pharmaceutical Sector and Public Health Safeguards

On August 25, 2023, the Indian Patent Office published the Draft Patents (Amendments) Rules, 2023, asking for feedback from various stakeholders. The Draft Rules propose several changes raising concerns about their potential impact on the Pharmaceutical Sector and public health standards. In this blog, we will closely examine these proposed amendments, focusing on key areas […]
Read more

Interim Injunction Denied in Patent Infringement Case: Plaintiffs Fail to Establish Prima Facie Case for Evergreening Patent

Introduction Genus-Species patent applications offer a valuable approach to patent protection, especially in the pharmaceutical domain. By combining a broad genus patent with specific species patents, inventors can secure comprehensive coverage while allowing for future innovations within the invention’s scope. However, to ensure patentability, these applications must adhere to the requirements outlined by the Indian […]
Read more

Understanding the Draft Patents (Amendment) Rules 2023: An Analysis

Understanding the Draft Patents (Amendment) Rules 2023: An Analysis   The Indian Patent framework is poised for another significant transformation, with the Ministry of Commerce and Industry unveiling the draft Patents (Amendment) Rules 2023. In light of the country’s burgeoning industrial landscape, these rules have been initiated by the Department for Promotion of Industry and […]
Read more

Balancing Comprehensiveness and Clarity: Decoding the Microsoft Case on Method and System Claims

In the intricate realm of intellectual property, patent applications stand as sentinels, safeguarding the ramparts of innovation. Yet, there lies an inherent tension within their walls: the recurring debate surrounding the coexistence of method and system claims in a single patent application. While the ethos behind such claims is to ensure holistic protection, many challenge […]
Read more

Securities and Exchange Board of India Issues Advertisement Code for Investment Advisers and Research Analysts

In a proactive move to safeguard the interests of investors in the Indian securities market, the Securities and Exchange Board of India (SEBI) has recently introduced a comprehensive Advertising Code for Investment Advisors (IA) and Research Analysts (RA) [1]. Through this circular, dated April 2023, SEBI aims to bolster the existing code of conduct under […]
Read more

Reach us at